Search
Search Results
##search.searchResults.foundPlural##
-
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2375PDF: 997HTML: 1647Fig 1: 185Tab I: 210Cover Letter: 205 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2031PDF: 825HTML: 214 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1630PDF: 1093HTML: 119 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2453PDF: 785HTML: 1735 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4360PDF: 909HTML: 1325Table1: 181 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2857PDF: 1436HTML: 3045Cover Letter: 207 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1615PDF: 807HTML: 165 -
WHAT ARE FUNGAL INFECTIONS?
4187PDF: 2382HTML: 27595de Pauw: 235 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4104PDF: 1587HTML: 952 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2221PDF: 1046HTML: 1982Characteristic of study group: 198 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1304PDF: 611HTML: 232 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4062PDF: 1928HTML: 5234Table 1: 190 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1465PDF: 764Suppl. Files: 323Html: 136 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1678PDF: 806HTML: 936cover letter: 268 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1392PDF: 819HTML: 3123 -
Acquired Hemophilia A successfully treated with rituximab
1936PDF: 1143HTML: 1458Figure 1: 175 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1101PDF: 544HTML: 1690Figures: 167Fifures Sanz: 176tables Sanz: 180Untitled: 176 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1376HTML: 404PDF: 821 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1488PDF: 770HTML: 203 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3252PDF: 1709HTML: 1086 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2136PDF: 1323HTML: 3501 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1760PDF: 571HTML: 283 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2801PDF: 1009HTML: 5520 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1789PDF: 819HTML: 227







